A high-resolution view of intra-tumoral B cell immunity.
Journal
Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918
Informations de publication
Date de publication:
08 03 2022
08 03 2022
Historique:
entrez:
9
3
2022
pubmed:
10
3
2022
medline:
6
5
2022
Statut:
ppublish
Résumé
In this issue of Immunity, Meylan et al. (2022) uses spatial transcriptomics to examine B cell immunity within intratumoral tertiary lymphoid structures (TLSs). They find that B cells expand and mature into plasma cells (PCs) within the TLS, migrate along fibroblastic tracks to tumor beds, and produce IgG antibodies that target cancer cells.
Identifiants
pubmed: 35263565
pii: S1074-7613(22)00089-9
doi: 10.1016/j.immuni.2022.02.009
pii:
doi:
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
387-389Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests X.S.L. is a board member and shareholder of GV20 Oncotherapy and the CEO of its subsidiary, GV20 Therapeutics. X.H. is a shareholder of GV20 Oncotherapy and the Chief Information Officer of its subsidiary, GV20 Therapeutics.